Paul Hershberger

671 total citations
20 papers, 397 citations indexed

About

Paul Hershberger is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Paul Hershberger has authored 20 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 4 papers in Organic Chemistry. Recurrent topics in Paul Hershberger's work include Receptor Mechanisms and Signaling (5 papers), Neuropeptides and Animal Physiology (4 papers) and Cancer therapeutics and mechanisms (3 papers). Paul Hershberger is often cited by papers focused on Receptor Mechanisms and Signaling (5 papers), Neuropeptides and Animal Physiology (4 papers) and Cancer therapeutics and mechanisms (3 papers). Paul Hershberger collaborates with scholars based in United States and Japan. Paul Hershberger's co-authors include Jeffrey D. Winkler, Satyamaheshwar Peddibhotla, Patrick Maloney, Anthony B. Pinkerton, Marc G. Caron, Michael P. Hedrick, Yushi Bai, Lawrence S Barak, James P. Springer and Layton H. Smith and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Paul Hershberger

20 papers receiving 388 citations

Peers

Countries citing papers authored by Paul Hershberger

Since Specialization

Citations

This map shows the geographic impact of Paul Hershberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Hershberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Hershberger more than expected).

Fields of papers citing papers by Paul Hershberger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Hershberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Hershberger. The network helps show where Paul Hershberger may publish in the future.

Co-authorship network of co-authors of Paul Hershberger

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Hershberger. A scholar is included among the top collaborators of Paul Hershberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Hershberger. Paul Hershberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of Anthranilic Acid Derivatives as Difluoromethylornithine Adjunct Agents That Inhibit Far Upstream Element Binding Protein 1 (FUBP1) Function 2022 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Mukund P. Tantak, (unknown), (unknown), (unknown), (unknown), Paul Hershberger, Patrick Maloney, Satyamaheshwar Peddibhotla, Eliot Sugarman, Sally A. Litherland, J. Pablo Arnoletti, (unknown), David Levens, Otto Phanstiel	4
2	Optimization of a urea-containing series of nicotinamide phosphoribosyltransferase (NAMPT) activators 2021 ·Bioorganic & Medicinal Chemistry Letters ·Anthony B. Pinkerton, E. Hampton Sessions, Paul Hershberger, Patrick Maloney, Satyamaheshwar Peddibhotla, (unknown), Eduard Sergienko, Chen-Ting Ma, Layton H. Smith, Michael R. Jackson, Jun Tanaka, Takashi Tsuji, (unknown), (unknown), Tsuyoshi Nakamura, Stephen J. Gardell	15
3	Discovery of small molecule guanylyl cyclase A receptor positive allosteric modulators 2021 ·Proceedings of the National Academy of Sciences ·S. Jeson Sangaralingham, Kanupriya Whig, Satyamaheshwar Peddibhotla, R. Jason Kirby, (unknown), Patrick Maloney, Paul Hershberger, (unknown), Becky Hood, Stefan Vasile, Shuchong Pan, Ye Zheng, Siobhan Malany, John C. Burnett	13
4	β-Arrestin-Biased Allosteric Modulator of NTSR1 Selectively Attenuates Addictive Behaviors 2020 ·Cell ·Lauren M. Slosky, Yushi Bai, Krisztián Tóth, (unknown), Lauren K. Rochelle, Alexandra Badea, Rahul Chandrasekhar, Vladimir M. Pogorelov, Dennis Abraham, (unknown), Satyamaheshwar Peddibhotla, Michael P. Hedrick, Paul Hershberger, Patrick Maloney, Hong Yuan, Zibo Li, William C. Wetsel, Anthony B. Pinkerton, Lawrence S Barak, Marc G. Caron	94
5	Dipyridamole Inhibits Lipogenic Gene Expression by Retaining SCAP-SREBP in the Endoplasmic Reticulum 2020 ·Cell chemical biology ·Ryan M. Esquejo, Manuel Roqueta‐Rivera, Wei Shao, Peter E. Phelan, Uthpala Seneviratne, Christopher W. am Ende, Paul Hershberger, Carolyn E. Machamer, Peter J. Espenshade, Timothy F. Osborne	17
6	Discovery of small molecule antagonists of chemokine receptor CXCR6 that arrest tumor growth in SK-HEP-1 mouse xenografts as a model of hepatocellular carcinoma 2019 ·Bioorganic & Medicinal Chemistry Letters ·Satyamaheshwar Peddibhotla, Paul Hershberger, R. Jason Kirby, Eliot Sugarman, Patrick Maloney, E. Hampton Sessions, Daniela Divlianska, (unknown), (unknown), Anthony B. Pinkerton, Layton H. Smith, (unknown)	15
7	Discovery of β-Arrestin Biased, Orally Bioavailable, and CNS Penetrant Neurotensin Receptor 1 (NTR1) Allosteric Modulators 2019 ·Journal of Medicinal Chemistry ·Anthony B. Pinkerton, Satyamaheshwar Peddibhotla, (unknown), Lauren M. Slosky, Yushi Bai, Patrick Maloney, Paul Hershberger, Michael P. Hedrick, (unknown), Robert Ardecky, Layton H. Smith, Thomas D.Y. Chung, Michael R. Jackson, Marc G. Caron, Lawrence S Barak	32
8	Repurposing antimalarial aminoquinolines and related compounds for treatment of retinal neovascularization 2018 ·PLoS ONE ·(unknown), Khandaker Siddiquee, (unknown), András Szabó, Stefan Vasile, Patrick Maloney, Daniela Divlianska, Satyamaheshwar Peddibhotla, (unknown), Paul Hershberger, (unknown), (unknown), (unknown), Rafal Farjo, Anthony B. Pinkerton, (unknown), (unknown), Michael E. Boulton, Maria B. Grant, Layton H. Smith	11
9	Discovery of Novel Small-Molecule Inducers of Heme Oxygenase-1 That Protect Human iPSC-Derived Cardiomyocytes from Oxidative Stress 2017 ·Journal of Pharmacology and Experimental Therapeutics ·R. Jason Kirby, Daniela Divlianska, Kanupriya Whig, (unknown), (unknown), Ada Koo, Becky Hood, (unknown), Patrick Maloney, (unknown), E. Hampton Sessions, Paul Hershberger, Layton H. Smith, Siobhan Malany	21
10	ML314: A Biased Neurotensin Receptor Ligand for Methamphetamine Abuse 2016 ·ACS Chemical Biology ·Larry S. Barak, Yushi Bai, Sean M. Peterson, Tama Evron, Nikhil M. Urs, Satyamaheshwar Peddibhotla, Michael P. Hedrick, Paul Hershberger, Patrick Maloney, Thomas D.Y. Chung, Ramona M. Rodriguiz, William C. Wetsel, James B. Thomas, Glen R. Hanson, Anthony B. Pinkerton, Marc G. Caron	37
11	Discovery of ML358, a Selective Small Molecule Inhibitor of the SKN-1 Pathway Involved in Drug Detoxification and Resistance in Nematodes 2015 ·ACS Chemical Biology ·Satyamaheshwar Peddibhotla, (unknown), Chi K. Leung, Patrick Maloney, Paul Hershberger, Ying Wang, (unknown), Hendrik Luesch, Arianna Mangravita-Novo, Anthony B. Pinkerton, Layton H. Smith, (unknown), Keith Choe	12
12	A high throughput screen for inhibitors of nematode detoxification genes 2014 ·Europe PMC (PubMed Central) ·Satyamaheshwar Peddibhotla, Chi K. Leung, Patrick Maloney, Paul Hershberger, Kevin Nguyen, Stefan Vasile, Eigo Suyama, (unknown), (unknown), (unknown), (unknown), Arianna Mangravita-Novo, Sumeet Salaniwal, Paul Kung, (unknown), Layton H. Smith, Thomas D.Y. Chung, Anthony B. Pinkerton, (unknown), Keith Choe	2
13	Synthesis and physicochemical characterization of novel phenotypic probes targeting the nuclear factor-kappa B signaling pathway 2013 ·Beilstein Journal of Organic Chemistry ·Paul Hershberger, Satyamaheshwar Peddibhotla, E. Hampton Sessions, Daniela Divlianska, Ricardo G. Correa, Anthony B. Pinkerton, John C. Reed, Gregory P. Roth	6
14	Imidazole-derived agonists for the neurotensin 1 receptor 2013 ·Bioorganic & Medicinal Chemistry Letters ·Paul Hershberger, Michael P. Hedrick, Satyamaheshwar Peddibhotla, Arianna Mangravita-Novo, (unknown), Yujie Li, (unknown), Michael Vicchiarelli, Layton H. Smith, Thomas D.Y. Chung, James B. Thomas, Marc G. Caron, Anthony B. Pinkerton, Lawrence S Barak, Gregory P. Roth	14
15	Development of a Quantitative Structure−Activity Relationship Model for Inhibition of Gram-positive Bacterial Cell Growth by Biarylamides 2003 ·Journal of Chemical Information and Computer Sciences ·David T. Stanton, (unknown), (unknown), Timothy W. Morris, Paul Hershberger, Christian N. Parker	3
16	The identification and characterization of hydrazinyl urea-based antibacterial agents through combinatorial chemistry 2001 ·Bioorganic & Medicinal Chemistry Letters ·Lawrence J. Wilson, Timothy W. Morris, (unknown), Paul J. Renick, Christian N. Parker, Michael C. Davis, (unknown), Paul Hershberger, (unknown), (unknown), Shyam Sunder, D. I. Jones, (unknown), Roy L. M. Dobson, (unknown), Kenneth L. Morand, (unknown)	12
17	Concept, Design, and Preclinical Evaluation of Quinolonyl Lactam Antibacterials 1998 ·Advances in experimental medicine and biology ·Paul Hershberger, Thomas Demuth	6
18	Preparation and Antimicrobial Assessment of 2-Thioether-linked Quinolonyl-carbapenems. 1998 ·The Journal of Antibiotics ·Paul Hershberger, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), W. G. Kraft, (unknown), (unknown), Suzanne M. Paule, Richard Siehnel, (unknown), (unknown), (unknown)	9
19	A stereoselective synthesis of (-)-perhydrohistrionicotoxin 1989 ·Journal of the American Chemical Society ·Jeffrey D. Winkler, Paul Hershberger	51
20	A stereoselective synthesis of the azaspiboundecane ring system of (−)-histrionicotoxin from (+)-glutamic acid 1986 ·Tetrahedron Letters ·Jeffrey D. Winkler, Paul Hershberger, James P. Springer	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact